{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:48:59Z","timestamp":1790401739518,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T00:00:00Z","timestamp":1726099200000},"content-version":"vor","delay-in-days":377,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.jacc.2023.06.021","type":"journal-article","created":{"date-parts":[[2023,8,27]],"date-time":"2023-08-27T07:32:53Z","timestamp":1693121573000},"page":"1080-1091","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Underutilization of Mineralocorticoid Antagonists in Patients With Heart\u00a0Failure With\u00a0Reduced\u00a0Ejection Fraction"],"prefix":"10.1016","volume":"82","author":[{"given":"Shingo","family":"Matsumoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pardeep S.","family":"Jhund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross T.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Swedberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk J.","family":"van Veldhuisen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart J.","family":"Pocock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertram","family":"Pitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7456-1570","authenticated-orcid":false,"given":"Faiez","family":"Zannad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6317-3975","authenticated-orcid":false,"given":"John J.V.","family":"McMurray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2023.06.021_bib1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1009492","article-title":"Eplerenone in patients with systolic heart failure and mild symptoms","volume":"364","author":"Zannad","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.06.021_bib2","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"Randomized Aldactone Evaluation Study Investigators. The effect of spironolactone on morbidity and mortality in patients with severe heart failure","volume":"341","author":"Pitt","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.06.021_bib3","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N\u00a0Engl J Med"},{"issue":"17","key":"10.1016\/j.jacc.2023.06.021_bib4","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Heidenreich","year":"2022","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.06.021_bib5","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.06.021_bib6","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1001\/jama.2009.1493","article-title":"Use of aldosterone antagonists in heart failure","volume":"302","author":"Albert","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.06.021_bib7","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.jacc.2023.02.040","article-title":"The EHR has exposed an urgent moral imperative to improve heart failure care","volume":"81","author":"Ahmad","year":"2023","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.06.021_bib8","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.jacc.2023.02.005","article-title":"Cluster-randomized trial comparing ambulatory decision support tools to improve heart failure care","volume":"81","author":"Mukhopadhyay","year":"2023","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.06.021_bib9","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/ejhf.2441","article-title":"A\u00a0promise unfulfilled: the use of mineralocorticoid receptor antagonists in patients with heart failure and a reduced left ventricular ejection fraction","volume":"24","author":"Pitt","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2023.06.021_bib10","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1002\/ehf2.12972","article-title":"Relationship between duration of heart failure, patient characteristics, outcomes, and effect of therapy in PARADIGM-HF","volume":"7","author":"Yeoh","year":"2020","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.jacc.2023.06.021_bib11","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.120.007879","article-title":"Patient characteristics, clinical outcomes, and effect of dapagliflozin in relation to duration of heart failure: is it ever too late to start a new therapy?","volume":"13","author":"Yeoh","year":"2020","journal-title":"Circ Heart Fail"},{"issue":"14","key":"10.1016\/j.jacc.2023.06.021_bib12","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1161\/CIRCULATIONAHA.122.062918","article-title":"Patient characteristics, outcomes, and effects of dapagliflozin according to the duration of heart failure: a prespecified analysis of the DELIVER trial","volume":"147","author":"Kondo","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.06.021_bib13","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1016\/j.jacc.2017.04.043","article-title":"Hospitalization for recently diagnosed versus worsening chronic heart failure: from the ASCEND-HF trial","volume":"69","author":"Greene","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.06.021_bib14","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/ejhf.1021","article-title":"Duration of chronic heart failure affects outcomes with preserved effects of heart rate reduction with ivabradine: findings from SHIFT","volume":"20","author":"B\u00f6hm","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2023.06.021_bib15","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.amjcard.2019.05.031","article-title":"Differences in mortality of new-onset (de-novo) acute heart failure versus acute decompensated chronic heart failure","volume":"124","author":"Younis","year":"2019","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2023.06.021_bib16","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2022-002022","article-title":"Motives, frequency, predictors and outcomes of MRA discontinuation in a real-world heart failure population","volume":"9","author":"Jonsson Holmdahl","year":"2022","journal-title":"Open Heart"},{"key":"10.1016\/j.jacc.2023.06.021_bib17","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1002\/ejhf.1182","article-title":"Factors associated with underuse of mineralocorticoid receptor antagonists in heart failure with reduced ejection fraction: an analysis of 11 215 patients from the Swedish Heart\u00a0Failure Registry","volume":"20","author":"Savarese","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2023.06.021_bib18","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/ehf2.14137","article-title":"Hyperkalaemia as a cause of undertreatment with mineralocorticoid receptor antagonists in heart failure","volume":"10","author":"Henrysson","year":"2023","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.jacc.2023.06.021_bib19","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/ejhf.2418","article-title":"Temporal trends in initiation of mineralocorticoid receptor antagonists and risk of subsequent withdrawal in patients with heart failure: a nationwide study in Denmark from 2003-2017","volume":"24","author":"Zahir","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2023.06.021_bib20","first-page":"201","article-title":"Impact of geographic region on the COMMANDER-HF trial","volume":"9","author":"Ferreira","year":"2021","journal-title":"J\u00a0Am Coll Cardiol HF"},{"key":"10.1016\/j.jacc.2023.06.021_bib21","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1007\/s00392-019-01588-7","article-title":"Geographical differences in heart failure characteristics and treatment across Europe: results from the BIOSTAT-CHF study","volume":"109","author":"Lombardi","year":"2020","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.jacc.2023.06.021_bib22","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1007\/s00392-019-01515-w","article-title":"Association of heart failure duration with clinical prognosis in advanced heart failure","volume":"109","author":"Sugiura","year":"2020","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.jacc.2023.06.021_bib23","doi-asserted-by":"crossref","first-page":"e412","DOI":"10.1002\/ccd.29390","article-title":"Association of heart failure duration with clinical outcomes after transcatheter mitral valve repair for functional mitral regurgitation","volume":"98","author":"Sugiura","year":"2021","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2023.06.021_bib24","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/eurjhf\/hft028","article-title":"Heart failure in elderly patients: distinctive features and unresolved issues","volume":"15","author":"Lazzarini","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2023.06.021_bib25","first-page":"1056","article-title":"Impact of age on comorbidities and outcomes in heart failure with reduced ejection fraction","volume":"7","author":"Regan","year":"2019","journal-title":"J\u00a0Am Coll Cardiol HF"},{"key":"10.1016\/j.jacc.2023.06.021_bib26","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1161\/CIRCULATIONAHA.121.052792","article-title":"Evidence-based medical therapy in patients with heart failure with reduced ejection fraction and chronic kidney disease","volume":"145","author":"Beldhuis","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.06.021_bib27","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1161\/CIRCULATIONAHA.109.895235","article-title":"Aldosterone receptor antagonists: effective but often forgotten","volume":"121","author":"Maron","year":"2010","journal-title":"Circulation"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109723060734?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109723060734?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T13:15:19Z","timestamp":1738934119000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109723060734"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":27,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S0735109723060734"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2023.06.021","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Underutilization of Mineralocorticoid Antagonists in Patients With Heart\u00a0Failure With\u00a0Reduced\u00a0Ejection Fraction","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2023.06.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}